Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: A pilot study

Laura Fernandez-Lopez, Cinta Folch, Xavier Majo, Laia Gasulla, Jordi Casabona

    Research output: Contribution to journalArticleResearchpeer-review

    18 Citations (Scopus)

    Abstract

    © 2016 Informa UK Limited. Including HCV and HIV rapid tests in harm reduction programmes (HRP) for people who inject drugs (PWID) can increase detection of these infections in high-risk populations who do not seek conventional health care. Aims: To assess acceptability and feasibility of rapid HIV and HCV tests in HRP; to identify HIV and HCV prevalence rates in HRP; to identify the percentage of PWID with a reactive test that attend hospital for confirmation and follow-up. Rapid oral tests for HCV and HIV were offered to users of 13 HRP from both mobile units and facility-based centres. A total of 172 HCV and 198 HIV tests were performed, with a refusal rate of 1.7% and 10.4%, respectively. Injectors made up 64.9% of all drug users and 35.1% did not inject drugs. Overall, 20.3% of HCV tests and 2.5% of HIV test were reactive. Only 24 of the 35 reactive HCV could be confirmed (68.6%) and one was false-negative. Of the five HIV reactive cases, only two could be confirmed (40%) with 1 false-positive case. Acceptability of rapid HIV and HCV tests among HRP users was high. The usefulness of oral rapid tests in HRP has been demonstrated, especially in mobile HRP.
    Original languageEnglish
    Pages (from-to)712-716
    JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
    Volume28
    Issue number6
    DOIs
    Publication statusPublished - 2 Jun 2016

    Keywords

    • harm reduction programmes
    • HCV
    • HIV
    • IDU
    • rapid tests

    Fingerprint

    Dive into the research topics of 'Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: A pilot study'. Together they form a unique fingerprint.

    Cite this